Articles related to Oncology, Radiation

Explore how the persistence of detectable Epstein-Barr virus DNA can serve as a significant predictive marker for nasopharyngeal cancer, potentially revolutionizing early diagnosis and improving survival rates.

The results of the WU-KONG6 study offer hope for NSCLC patients with EGFR exon20 insertion mutations, demonstrating the substantial antitumor efficacy of sunvozertinib.

Join this crucial journey to broaden your comprehension of CAR T-cell therapy, CRS and ICANS management, and learn how to utilize this knowledge for better patient outcomes in the battle against relapsed/refractory multiple myeloma.

Explore the groundbreaking findings from the TROPiCS-02 study, revealing sacituzumab govitecan as a potential game-changer in the treatment of endocrine refractory metastatic hormone receptor-positive breast cancer.

As physicians navigate the shifting sands of healthcare policies, Cigna’s latest decision serves as a reminder of the need for streamlined processes and clear communication. Discover how this policy change may impact your practice and patient care.

A phase II trial showed a significant progression-free survival benefit when patients with HR+/HER2- metastatic breast cancer switched endocrine therapy and received ribociclib, indicating the potential of this treatment strategy for those who progress on endocrine therapy and palbociclib. Learn more about the findings and implications for clinical practice.